A systemic study of enhancement of host defense processes against bacterial infection

Abstract

A sequence of studies over more than two decades has identified a variety of host defense abnormalities that may contribute to clinical infection in high risk and/or badly injured patients. Clearly, animal studies set the stage for our clinical applications and suggest that a variety of so-called non-specific host defense stimulants may indeed correct many of these abnormalities and promote the ultimate control of surgical infections.